These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5670861)

  • 1. The adverse drug reaction reporting scheme and the Australian drug evaluation committee.
    Walshe AM
    Med J Aust; 1968 Jul; 2(2):82-5. PubMed ID: 5670861
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse Drug Reactions Advisory Committee Report for 1976.
    Med J Aust; 1977 Nov; 2(20):682-3. PubMed ID: 607116
    [No Abstract]   [Full Text] [Related]  

  • 3. Reporting adverse reactions.
    Steen J
    Lancet; 1978 Oct; 2(8096):947. PubMed ID: 81965
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of restrictive actions under the Australian drug regulatory system.
    Dukes MN; Lunde I
    Med J Aust; 1982 May; 1(10):412-5. PubMed ID: 7099069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions: a hospital pharmacy-based reporting scheme.
    Winstanley PA; Irvin LE; Smith JC; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jul; 28(1):113-6. PubMed ID: 2775609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of voluntary adverse drug reaction reports and corresponding medical records.
    Troutman WG; Doherty KM
    Am J Health Syst Pharm; 2003 Mar; 60(6):572-5. PubMed ID: 12659060
    [No Abstract]   [Full Text] [Related]  

  • 7. ADVERSE DRUG REACTIONS AND THE AUSTRALIAN DRUG EVALUATION COMMITTEE.
    GAULT JE
    Med J Aust; 1964 Jul; 2():153-4. PubMed ID: 14176467
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety.
    Boyd IW
    Toxicology; 2002 Dec; 181-182():99-102. PubMed ID: 12505292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods of monitoring adverse reactions to drugs.
    Venulet J
    Prog Drug Res; 1977; 21():231-92. PubMed ID: 339270
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of spontaneous reports of adverse reactions to drugs.
    Inman WH; Evans DA
    Br Med J; 1972 Sep; 3(5829):746-9. PubMed ID: 5077919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience of clinical pharmacology and clinical pharmacy interactions in a clinical pharmacokinetics consultation service.
    Taylor JW; McLean AJ; Leonard RG; Ludden TM; Clibon U; du Souich BP; Harris SC; Lalka D; Talbert RL; Vicuna N; Walton CA; McNay JL
    J Clin Pharmacol; 1979 Jan; 19(1):1-7. PubMed ID: 762251
    [No Abstract]   [Full Text] [Related]  

  • 13. Side-effects of drugs. Monitoring adverse reactions.
    Heenan A
    Nurs Times; 1989 Sep 27-Oct 3; 85(39):25-9. PubMed ID: 2587304
    [No Abstract]   [Full Text] [Related]  

  • 14. The structure and function of a clinical pharmacology consulting service.
    Spector R; Heller A; Johnson MW
    J Clin Pharmacol; 1979; 19(5-6):257-60. PubMed ID: 469021
    [No Abstract]   [Full Text] [Related]  

  • 15. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner].
    Kaiser RH
    Radiologe; 2002 Dec; 42(12):1016-24; quiz 1024-5. PubMed ID: 12602329
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?
    Venning GR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6361):289-92. PubMed ID: 6218859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug surveillance: the role of the Committee on Safety of Medicines.
    Griffin JP
    Ulster Med J; 1972; 41(2):111-20. PubMed ID: 5084689
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Australia's national medicines policy failing? The case of COX-2 inhibitors.
    Vitry A; Lexchin J; Mansfield PR
    Int J Health Serv; 2007; 37(4):735-44. PubMed ID: 18072318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: The drug makers.
    Med J Aust; 1974 Oct; 2(16):583-4. PubMed ID: 4437418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacovigilance in the framework of recording and control of drugs in the United Kingdom].
    Dunlop D
    Therapie; 1974; 29(6):799-804. PubMed ID: 4462229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.